1. Home
  2. BMRN vs TTAN Comparison

BMRN vs TTAN Comparison

Compare BMRN & TTAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • TTAN
  • Stock Information
  • Founded
  • BMRN 1996
  • TTAN 2012
  • Country
  • BMRN United States
  • TTAN United States
  • Employees
  • BMRN N/A
  • TTAN N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • TTAN
  • Sector
  • BMRN Health Care
  • TTAN
  • Exchange
  • BMRN Nasdaq
  • TTAN NYSE
  • Market Cap
  • BMRN 12.1B
  • TTAN 10.2B
  • IPO Year
  • BMRN 1999
  • TTAN 2024
  • Fundamental
  • Price
  • BMRN $55.00
  • TTAN $104.39
  • Analyst Decision
  • BMRN Buy
  • TTAN Buy
  • Analyst Count
  • BMRN 22
  • TTAN 14
  • Target Price
  • BMRN $93.43
  • TTAN $122.38
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • TTAN 1.7M
  • Earning Date
  • BMRN 08-04-2025
  • TTAN 06-05-2025
  • Dividend Yield
  • BMRN N/A
  • TTAN N/A
  • EPS Growth
  • BMRN 152.82
  • TTAN N/A
  • EPS
  • BMRN 2.71
  • TTAN N/A
  • Revenue
  • BMRN $2,950,227,000.00
  • TTAN $817,242,000.00
  • Revenue This Year
  • BMRN $12.23
  • TTAN $21.17
  • Revenue Next Year
  • BMRN $9.99
  • TTAN $13.87
  • P/E Ratio
  • BMRN $20.29
  • TTAN N/A
  • Revenue Growth
  • BMRN 19.36
  • TTAN 28.01
  • 52 Week Low
  • BMRN $52.93
  • TTAN $79.81
  • 52 Week High
  • BMRN $94.85
  • TTAN $131.33
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 35.12
  • TTAN N/A
  • Support Level
  • BMRN $54.46
  • TTAN N/A
  • Resistance Level
  • BMRN $58.17
  • TTAN N/A
  • Average True Range (ATR)
  • BMRN 1.39
  • TTAN 0.00
  • MACD
  • BMRN -0.04
  • TTAN 0.00
  • Stochastic Oscillator
  • BMRN 13.08
  • TTAN 0.00

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About TTAN SERVICETITAN INC

ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.

Share on Social Networks: